Related Experiment Video

Updated: Aug 19, 2026

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
10:36

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

Gonadotropin-releasing hormone receptor-targeted gene therapy of gynecologic cancers

Carsten Gründker1, Abdohamid Huschmand Nia, Günter Emons

  • 1Department of Gynecology and Obstetrics, Robert-Koch-Street 40, D-37099 Göttingen, Germany. grundker@med.uni-goettingen.de

Molecular Cancer Therapeutics
|February 17, 2005
PubMed

Insights

This study shows that gonadotropin-releasing hormone (GnRH) receptors are present in ovarian, endometrial, and breast cancers. A novel gene therapy approach utilizes GnRH analogues to target these specific cancer cells.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • The majority of ovarian, endometrial, and breast cancers express gonadotropin-releasing hormone (GnRH) receptors.
  • GnRH receptor signaling in these tumors differs from that in pituitary gonadotrophs, suggesting a tumor-specific pathway.
  • GnRH receptors are not expressed in other organs or hematopoietic stem cells.

Purpose of the Study:

  • To investigate the potential of targeting GnRH receptors in specific cancers.
  • To develop and test a gene therapy concept utilizing tumor-specific GnRH receptor signaling.

Main Methods:

  • Analysis of GnRH receptor expression in ovarian, endometrial, and breast cancers.
  • Investigation of GnRH receptor signal transduction pathways in tumor cells.
  • Development and in vitro/in vivo testing of a gene therapy strategy using GnRH analogues.

Main Results:

  • Specific activation of nuclear factor kappaB was observed in cancer cells treated with GnRH agonists.
  • A gene therapy concept using GnRH analogues successfully induced therapeutic gene transcription in cell cultures and nude mice.
  • The study confirmed a tumor-specific signaling pathway mediated by GnRH receptors.

Conclusions:

  • GnRH receptor expression and signaling in ovarian, endometrial, and breast cancers present a viable therapeutic target.
  • A novel gene therapy approach using GnRH analogues demonstrates potential for treating these specific cancers.
  • The findings support the development of targeted therapies based on tumor-specific GnRH receptor pathways.

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.